High-Dimensional Analysis of Single-Cell Flow Cytometry Data Predicts Relapse in Childhood Acute Lymphoblastic Leukaemia

Artificial intelligence methods may help in unveiling information that is hidden in high-dimensional oncological data. Flow cytometry studies of haematological malignancies provide quantitative data with the potential to be used for the construction of response biomarkers. Many computational methods...

Full description

Saved in:
Bibliographic Details
Published inCancers Vol. 13; no. 1; p. 17
Main Authors Chulián, Salvador, Martínez-Rubio, Álvaro, Pérez-García, Víctor M, Rosa, María, Blázquez Goñi, Cristina, Rodríguez Gutiérrez, Juan Francisco, Hermosín-Ramos, Lourdes, Molinos Quintana, Águeda, Caballero-Velázquez, Teresa, Ramírez-Orellana, Manuel, Castillo Robleda, Ana, Fernández-Martínez, Juan Luis
Format Journal Article
LanguageEnglish
Published Switzerland MDPI 23.12.2020
MDPI AG
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Artificial intelligence methods may help in unveiling information that is hidden in high-dimensional oncological data. Flow cytometry studies of haematological malignancies provide quantitative data with the potential to be used for the construction of response biomarkers. Many computational methods from the bioinformatics toolbox can be applied to these data, but they have not been exploited in their full potential in leukaemias, specifically for the case of childhood B-cell Acute Lymphoblastic Leukaemia. In this paper, we analysed flow cytometry data that were obtained at diagnosis from 56 paediatric B-cell Acute Lymphoblastic Leukaemia patients from two local institutions. Our aim was to assess the prognostic potential of immunophenotypical marker expression intensity. We constructed classifiers that are based on the Fisher's Ratio to quantify differences between patients with relapsing and non-relapsing disease. We also correlated this with genetic information. The main result that arises from the data was the association between subexpression of marker CD38 and the probability of relapse.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
Current address: Department of Mathematics, Mathematical Oncology Laboratory (MOLAB), Universidad de Castilla-La Mancha, 13071 Ciudad Real, Spain.
ISSN:2072-6694
2072-6694
DOI:10.3390/cancers13010017